Pharmacovigilance for plasma-derived clotting factor concentrates.
Tagariello
G
G
Cavallin
F
F
Davoli
P G
PG
Gajo
G B
GB
De Biasi
E
E
Traldi
A
A
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D001779:Blood Coagulation Factors / Q000009:adverse effects / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans
D001779:Blood Coagulation Factors